Literature DB >> 8105030

Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.

S J Kish1, Y Robitaille, M el-Awar, L Schut, L DiStefano, M J Ball, M F Mazurek.   

Abstract

Somatostatin-like immunoreactivity (SLI) was measured in the brains of nine patients with dominantly inherited olivopontocerebellar atrophy (OPCA), who all had a marked deficit of the cholinergic marker choline-acetyltransferase (ChAT) in the cerebral cortex and striatum. Mean concentrations of SLI in OPCA were significantly reduced by 42-58% in parietal and occipital cortices and frontal cortical eye fields, but were normal in other cortical areas, including two subdivisions of the temporal cortex which show marked depletions of both SLI and ChAT in Alzheimer's disease. This dissociation of SLI and ChAT indicates that a cortical cholinergic deficit does not invariably lead to reduction of somatostatin. In the caudate nucleus, the region of OPCA brain having the most severe ChAT deficit (-81%), SLI levels were significantly elevated by 46% and were negatively and significantly correlated with ChAT activities (r = -0.66). The SLI alterations could be due to abnormal somatostatin metabolism or release, or an increased number of somatostatin-containing neurons and could contribute to the brain dysfunction of OPCA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105030      PMCID: PMC489740          DOI: 10.1136/jnnp.56.9.1013

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

Review 2.  Somatostatin: alterations in the central nervous system in neurological diseases.

Authors:  M F Beal; G Uhl; M F Mazurek; N Kowall; J B Martin
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1986

3.  Somatostatin-like immunoreactivity within neuritic plaques.

Authors:  D M Armstrong; S LeRoy; D Shields; R D Terry
Journal:  Brain Res       Date:  1985-07-08       Impact factor: 3.252

4.  Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.

Authors:  M F Beal; M F Mazurek; G K Chattha; C N Svendsen; E D Bird; J B Martin
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

5.  Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.

Authors:  M F Beal; M F Mazurek; C N Svendsen; E D Bird; J B Martin
Journal:  Ann Neurol       Date:  1986-10       Impact factor: 10.422

6.  Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy.

Authors:  S J Kish; Y Robitaille; M el-Awar; B Clark; L Schut; M J Ball; L T Young; R Currier; K Shannak
Journal:  Neurology       Date:  1992-08       Impact factor: 9.910

7.  Somatostatin and dementia in Parkinson's disease.

Authors:  J Epelbaum; M Ruberg; E Moyse; F Javoy-Agid; B Dubois; Y Agid
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

8.  Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei.

Authors:  M F Chesselet; T D Reisine
Journal:  J Neurosci       Date:  1983-01       Impact factor: 6.167

9.  Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons.

Authors:  B M Chronwall; T N Chase; T L O'Donohue
Journal:  Neurosci Lett       Date:  1984-12-21       Impact factor: 3.046

10.  Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.

Authors:  G W Roberts; T J Crow; J M Polak
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.